Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » Newsletters

Newsletters

Opal Biosciences Investor Briefing, Sydney 13 July 2015

Opal Biosciences Investor Briefing, Melbourne 14 July 2015

Latest News

Receipt of 2016 Income Tax Return Refund

May 22, 2017

20170522 Receipt of 2016 Income Tax Return Refund (BioDiem)

Read More
BioDiem Releases Half Year Results

March 17, 2017

BioDiem Releases Half Year Results

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions